Sanofi India DuPont analysis

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Dec 2025	FY25Dec 2024	FY24Dec 2023	FY23Dec 2022	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.74×	0.73×	0.96×	0.71×	0.72×
	1.04×	0.98×	0.95×	1.11×	1.30×
	26.0%	24.7%	22.6%	26.8%	23.9%
	1.28×	1.28×	1.21×	1.51×	1.34×
	1.67×	1.67×	1.87×	1.69×	1.62×
	42.9%	38.1%	46.5%	54.0%	48.7%
	40.6%	40.6%	44.1%	52.7%	48.6%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

SANOFI₹3,189.50

Sanofi India Limited

· Pharma & Health

₹ CrorePeersSENORES INNOVACAP PGHL MOREPENLAB IOLCP SANOFICONR FDC ORCHPHARMAMcap ₹7,336 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/12/2022	FY24 31/12/2023	FY25 31/12/2024	FY26 31/12/2025	Last 12M 30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.72	0.71	0.96	0.73	0.74
Interest Burden (Pretax/EBIT) ×	1.30	1.11	0.95	0.98	1.04
EBIT Margin %	23.92	26.81	22.56	24.71	25.99
Asset Turnover ×	1.34	1.51	1.21	1.28	1.28
Financial Leverage (Assets/Equity) ×	1.62	1.69	1.87	1.67	1.67
ROE (5-step product, year-end total equity) %	48.75	53.96	46.55	38.12	42.90
ROE (owners' profit / average owners' equity) %	48.64	52.65	44.08	40.59	40.59

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.